市場調查報告書
商品編碼
1622358
小動物影像市場規模、佔有率、成長分析、按模式、按應用、按試劑、按地區 - 產業預測,2025-2032Small Animal Imaging Market Size, Share, Growth Analysis, By Modality (Optical Imaging Systems, Nuclear Imaging), By Application (Monitoring Drug Treatment Response, Biodistribution Studies), By Reagent, By Region - Industry Forecast 2025-2032 |
2023年小動物影像市場規模為93.9億美元,從2024年的99.9億美元成長到2032年的164.4億美元,預計複合年成長率為6.42%。
由於其在藥物發現、疾病研究和生物過程闡明中的重要作用,全球小動物影像市場正在經歷顯著成長。該領域提供了對分子和細胞機制的重要見解,並促進了標靶治療和個人化治療策略的開發。製藥和生物技術產業依靠臨床前測試來評估候選藥物的安全性和有效性,極大地推動了對這些技術的需求。高解析度顯像模式和增強掃描功能等技術進步正在提高臨床前評估的準確性和效率,進一步推動市場擴張。此外,多模態成像技術和混合系統的整合擴展了小動物成像的能力,允許更豐富、更準確的資料收集,這對於推進研究和治療開發至關重要。
Small Animal Imaging Market size was valued at USD 9.39 Billion in 2023 and is poised to grow from USD 9.99 Billion in 2024 to USD 16.44 Billion by 2032, growing at a CAGR of 6.42% during the forecast period (2025-2032).
The global small animal imaging market is witnessing remarkable growth, driven by its vital role in drug discovery, disease research, and biological process understanding. This sector provides crucial insights into molecular and cellular mechanisms, facilitating the development of targeted therapies and personalized treatment strategies. The pharmaceutical and biotechnology industries significantly boost demand for these technologies, relying on preclinical studies to assess new drug candidates' safety and efficacy. Technological advancements, such as high-resolution imaging modalities and enhanced scanning capabilities, have further propelled market expansion, improving the accuracy and efficiency of preclinical assessments. Additionally, the integration of multimodal imaging techniques and hybrid systems has broadened small animal imaging's capabilities, allowing for richer and more precise data acquisition, crucial for advancing research and therapeutic development.
Top-down and bottom-up approaches were used to estimate and validate the size of the Small Animal Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Small Animal Imaging Market Segmental Analysis
Global Small Animal Imaging Market is segmented by modality, application, reagent and region. Based on modality, the market is segmented into optical imaging systems, nuclear imaging and other imaging modalities. Based on application, the market is segmented into monitoring drug treatment response, biodistribution studies, cancer cell detection, biomarkers, longitudinal studies and epigenetics. Based on reagents, the market is segmented into optical imaging reagents and nuclear imaging reagents. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Small Animal Imaging Market
The Small Animal Imaging market is primarily driven by the increasing focus on preclinical research within the pharmaceutical, biotechnology, and life sciences sectors. As the need for detailed investigations into diseases intensifies, the demand for sophisticated small animal imaging systems is on the rise. These cutting-edge imaging technologies provide researchers with the capability to perform comprehensive studies on various diseases, track their progression, assess the efficacy of treatments, and evaluate the safety and toxicity of novel drugs or therapies. This heightened emphasis on preclinical research is significantly contributing to the growth of the small animal imaging market.
Restraints in the Small Animal Imaging Market
The Small Animal Imaging market faces several constraints, notably the restricted availability of imaging agents. The process of developing and validating imaging agents specifically designed for preclinical studies can be both lengthy and expensive, which hinders their broader acceptance and use. This scarcity of suitable imaging agents can significantly affect the overall deployment of small animal imaging technologies within research environments, leading to potential delays in scientific progress and diminishing the effectiveness of preclinical studies. Consequently, this limitation may restrict researchers' ability to achieve comprehensive results, ultimately impacting the growth and application of the Small Animal Imaging market.
Market Trends of the Small Animal Imaging Market
The global small animal imaging market is witnessing a significant trend towards the increased adoption of multimodal imaging techniques, which integrate various imaging modalities to enhance the understanding of biological processes and disease progression in small animals. This trend is propelled by the demand for more precise and detailed imaging data in preclinical research and drug development. By utilizing a combination of techniques like positron emission tomography (PET), computed tomography (CT), magnetic resonance imaging (MRI), and optical imaging, researchers gain complementary insights that improve the sensitivity and specificity of imaging studies, ultimately fostering advancements in therapeutic efficacy and research outcomes.